Facebook Linkedin Twitter
Inside Precision Medicine 23andMe to Report Diabetes Risk

23andMe

23andMe to Report Diabetes Risk
Molecular Dx

23andMe to Report Diabetes Risk

0
GWAS Helps Uncover the Genomics of Mouth Ulcers
Molecular Dx

GWAS Helps Uncover the Genomics of Mouth Ulcers

0
Heart
News & Features

MyoKardia, 23andMe to Create HCM Digital Community

0
Patient Investment
News & Features

Patient Investment

0
dna molecules on abstract technology background
News & Features

23andMe Wins $300M Investment from GSK in Parkinson’s Disease Partnership

Alex Philippidis
0
Clinical OMICs Magazine Volume 5, Issue No. 3
News & Features

Clinical OMICs Magazine Volume 5, Issue No. 3

0
23andMe has raised an additional $250 million in growth financing
News & Features

23andMe Raises $250M, More Than Doubling Its Total Capital

0
23andMe and drug developer Grünenthal Group will partner on a study intended to glean insights into the genetics of pain.(Source: fred goldstein/Fotolia)
News & Features

23andMe, Grünenthal to Study the Genetics of Pain, with Targeted Treatments in Mind

0
Patient having a mouth swab test
Molecular Dx

FDA Grants Approval for 23andMe’s Direct-to-Consumer Genetic Health Risk Reports

0
Source: DepositPhotos/ Julia_Tim
Molecular Dx

Direct-to-Consumer Genetic Testing Study Reviews Value and Impact

0
123Page 2 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine